Republican Senator Steve Daines of Montana on Friday urged Americans to have confidence in them Coronavirus Vaccine off Pfizer and BioNTechCiting his experience as a participant in the Company’s Phase 3 clinical trial.
The US pharmaceutical company and the German biotech company said so earlier on Friday intends to apply for an emergency permit by the U.S. Food and Drug Administration, making them the first to do so for a Covid-19 vaccine. The final data released this week showed that the vaccine was 95% effective in preventing the disease. The FDA review process is expected to take a few weeks.
“This is great news for the American people. This is how we end this pandemic,” Daines said “The exchange.” “The reason my wife and I attended is because we want to help build trust in these vaccines.”
Daines said he didn’t experience any major side effects after receiving his first vaccination in the study in late August. Pfizer’s vaccine requires two doses. While participants in double-blind studies are not told whether they will receive the vaccine or a placebo, Daines has reason to believe that he did indeed receive the experimental candidate.
“It reminded me of the flu shot. It was practically painless, the vaccine itself. I had a bit of pain in my arm for a few days, and then I had a slight chills the day after that lasted about a couple of hours I felt just fine the next day, “said Daines, who Re-election won earlier this month. “That was probably an indicator that I had the vaccine.”
Daines is that second Republican Senator this week to announce its participation in vaccine trials. On Tuesday Sen. Rob Portman of Ohio said CNBC had signed up Johnson & JohnsonPhase three process. The men shared similar motives for signing up.
“It’s one thing to have the vaccines that I think will be ready by the end of this year, really in just a month and a half, but we have to be sure that people are ready to get vaccinated.” said Portman said. “The reason I took part in this study was because I think the vaccines are so important.”
The news of Pfizer and BioNTech’s FDA filing comes at a critical time in the U.S. coronavirus pandemic. Have new daily infections rose to a record level and so have hospitalizations for Covid-19 patients. On Thursday, deaths hit levels not seen since early May.
Several federal agencies have started telling workers that they could – or may – be vaccinated with the Covid-19 vaccine from Pfizer and BioNtech Modernaapproaching an FDA application – in just eight weeks, CNBC reported Fridayrelying on a person with knowledge of the plans.
Each approved coronavirus vaccine would initially be limited in its quantity. Healthcare workers, as well as the elderly and those with underlying health conditions, are likely to receive the vaccine first. Once the FDA approves, “the vaccines will be at the vaccination sites and people will be vaccinated within 24 hours,” said Dr. Moncef Slaoui, Advisor to Operation Warp Speed said CNBC on Friday.